Related Experiment Videos
MPP(+)-induced mitochondrial dysfunction is potentiated by dopamine
1Unitat de Biofísica, Universitat de Barcelona, Barcelona, Spain.
Abstract:
MPP(+), the major metabolite of the Parkinsonism-inducing compound MPTP, responsible for the destruction of the nigrostriatal pathway in primates and rodents, has been assayed in isolated rat liver mitochondria in the presence of physiological concentrations of dopamine or analogous concentrations of melanin-dopamine. 5 microM MPP(+) in the presence of 70 microM dopamine or melanin-dopamine, but not alone, decreased the heat production and oxygen consumption of a mitochondrial suspension activated with succinate and ADP. Both dopamine and oxidized dopamine plus MPP(+) also decreased the mitochondrial reductive power measured with MTT. Mitochondrial swelling was observed, associated with an increase in membrane mitochondrial potential, as a synergistic effect between low concentrations of MPP(+) and dopamine. It is suggested that cytosolic dopamine, by itself or via its autooxidation products, may play a relevant role in the mitochondrial toxicity of MPP(+). A failure in the regulation of the storage/release of dopamine could aggravate a mitochondrial damage and trigger the neurodegenerative process underlying MPTP toxicity and Parkinson's disease.
Insights
MPP(+) and dopamine synergistically damage mitochondria, impacting Parkinson's disease research. This study reveals how dopamine influences MPP(+) toxicity in liver mitochondria.
Area of Science:
- Neuroscience
- Biochemistry
- Toxicology
Background:
- MPP(+) is the toxic metabolite of MPTP, a compound that induces Parkinsonism.
- MPTP causes the destruction of the nigrostriatal pathway, a key area affected in Parkinson's disease.
Purpose of the Study:
- To investigate the role of dopamine in the mitochondrial toxicity of MPP(+).
- To explore the synergistic effects of MPP(+) and dopamine on isolated rat liver mitochondria.
Main Methods:
- Assay of MPP(+) in isolated rat liver mitochondria with dopamine or melanin-dopamine.
- Measurement of heat production, oxygen consumption, and mitochondrial reductive power (MTT assay).
- Observation of mitochondrial swelling and membrane potential changes.
Main Results:
- MPP(+) combined with dopamine or melanin-dopamine reduced mitochondrial heat production and oxygen consumption.
- Dopamine and oxidized dopamine with MPP(+) decreased mitochondrial reductive power.
- Synergistic mitochondrial swelling and increased membrane potential were observed with low concentrations of MPP(+) and dopamine.
Conclusions:
- Cytosolic dopamine or its oxidation products may significantly contribute to MPP(+) mitochondrial toxicity.
- Dysregulation of dopamine storage/release could exacerbate mitochondrial damage, potentially triggering Parkinson's disease neurodegeneration.
- Findings highlight dopamine's role in MPTP-induced neurotoxicity and Parkinson's disease pathogenesis.